Research background · Updated November 1, 2026
Hexarelin Acetate Research: Publications, Study Types and Background
Short answer
Hexarelin Acetate. As of November 1, 2026, PubMed indexes 291 records matching Hexarelin Acetate, the earliest from 1994; 12 were published in 2021–2025 and 23 are reviews. ClinicalTrials.gov lists 0 registered studies matching the compound.
- PubMed records
- 291
- Earliest record
- 1994
- Published 2021–2025
- 12
- Reviews
- 23
- Animal-only studies
- 107
- Registered studies
- 0
Publications per year, 2006–2025
39 records in 2016–2025 against 64 in 2006–2015; the busiest year was 2006, with 8.
See the numbers
| Year | PubMed records |
|---|---|
| 2006 | 8 |
| 2007 | 6 |
| 2008 | 8 |
| 2009 | 5 |
| 2010 | 8 |
| 2011 | 6 |
| 2012 | 7 |
| 2013 | 5 |
| 2014 | 7 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 7 |
| 2018 | 7 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 7 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
Study types
| All PubMed records | 291 |
|---|---|
| Reviews | 238% |
| Animal studies (no human subjects indexed) | 10737% |
| Indexed as clinical trials | 5820% |
| Registered on ClinicalTrials.gov | 0 |
Categories overlap and follow PubMed’s own indexing; recent records may not be indexed yet.
Primary research directions
What 2 of the most-cited and most recent Hexarelin Acetate papers report, in their own authors’ terms. Each line links the paper it came from.
Cardiovascular research
This review describes hexarelin as a synthetic growth hormone-releasing peptide that binds and activates the growth hormone secretagogue receptor, more chemically stable and functionally potent than ghrelin, and summarizes evidence on its cardiovascular actions.
ReviewMao Y 2014Journal of geriatric cardiologyPMID 25278975
Growth hormone secretagogue receptor
This review describes ghrelin and its synthetic analogue hexarelin as specific ligands of the growth hormone secretagogue receptor and summarizes their reported metabolic signalling.
ReviewMosa RM 2015EndocrinePMID 25645463
Most-studied topics
The Medical Subject Headings (MeSH) PubMed indexers most often marked as a main topic, across 291 of the 291 records. They describe what the literature is about, not what Hexarelin Acetate does.
- Growth Hormone80 papers
- Growth Substances60 papers
- Human Growth Hormone52 papers
- Growth Hormone-Releasing Hormone43 papers
- Peptide Hormones26 papers
- Adrenocorticotropic Hormone17 papers
- Hydrocortisone17 papers
- Pituitary Gland16 papers
Key papers
Earliest indexed record
Imbimbo BP (1994). European journal of clinical pharmacology.
PMID 7957536Most-cited paper · 602 citations
Baldanzi G (2002). The Journal of cell biology.
PMID 12486113Most-cited #2 · 579 citations
Broglio F (2001). The Journal of clinical endocrinology and metabolism.
PMID 11600590Most-cited #3 · 439 citations
Arvat E (2001). The Journal of clinical endocrinology and metabolism.
PMID 11238504
Citation counts from NIH iCite, among the 291 records sampled. Titles are left out; open each record on PubMed to read it.
Identity
| CAS | 140703-51-1 |
|---|---|
| Molecular formula | C47H58N12O6 |
| Molecular weight | 887.0 g/mol |
| Synonyms | Hexarelin, Examorelin, EP-23905, examorelina, examoreline |
Identity data from PubChem, retrieved November 1, 2026, on the Hexarelin Acetate page.
How these numbers were counted
- PubMed search, run November 1, 2026:
hexarelin[tiab]re-run it. Study types add PubMed’s own filters (review, clinical trial, animals not humans). - Topics: MeSH major-topic headings counted across up to 400 of the matching records; headings for study set-up (species, sex, age) are left out.
- Citations: NIH iCite citation counts for the same records.
- ClinicalTrials.gov search:
hexarelinre-run it. Any phase, any status.
This page reports what has been published and what papers say they found, with each source linked. It gives no dosing or usage information, and nothing here is a reason to use Hexarelin Acetate outside a laboratory.
Wholesale supply
Hexarelin Acetate, sourced to order for research.
Not held in the listed catalog. Tell us the vial size and the number of vials and we come back with availability, documentation and pricing in writing.
Hexarelin Acetate research questions
How much research has been published on Hexarelin Acetate?
PubMed indexes 291 records matching Hexarelin Acetate (searched November 1, 2026), including 23 reviews and 58 records indexed as clinical trials. 12 were published in the five years 2021–2025.
When was Hexarelin Acetate first described in the literature?
The earliest PubMed record matching Hexarelin Acetate is from 1994 (Imbimbo BP, European journal of clinical pharmacology, PMID 7957536).
What topics does the Hexarelin Acetate literature cover?
The subject headings PubMed indexers most often marked as a main topic of Hexarelin Acetate papers are Growth Hormone, Growth Substances, Human Growth Hormone, Growth Hormone-Releasing Hormone. These describe what the literature is about. Findings from individual papers, with their sources, are summarized on this page.
Is Hexarelin Acetate sold for human use?
No. Vanta Foundry supplies it for laboratory research use only. Not for human or veterinary use, and not a drug, food, cosmetic or dietary supplement.
Where can I buy Hexarelin Acetate wholesale for research?
We source Hexarelin Acetate to order rather than stock it. Tell us the vial size and number of vials on WhatsApp or by email and the quote confirms availability, documentation and pricing.
Research materials supplied by Vanta Foundry are for laboratory research use only. They are not for human or veterinary use and are not drugs, foods, cosmetics or dietary supplements. Websites and payment processing are business services for research-supply brands.
All compounds: research peptide publication statistics.